Crossmark

Introduction of a penicillin allergy de-labelling program with direct oral challenge and its effects on utilization of beta-lactam antimicrobials: a multicenter retrospective parallel cohort study

Crossref DOI link: https://doi.org/10.1186/s13223-024-00877-9

Published Online: 2024-03-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mir, Adhora

Lanoue, Derek

Zanichelli, Veronica

van Walraven, Carl

Olynych, Timothy

Nott, Caroline

MacFadden, Derek
Funding

Funding for this research was provided by:

Ottawa Hospital Research Institute
License Information

Text and Data Mining valid from 2024-03-05

Version of Record valid from 2024-03-05
More Information

Article History

Received: 3 August 2023

Accepted: 31 January 2024

First Online: 5 March 2024

Declarations

:

: Ethics approval from the <i>Ottawa Health Science Network Research Ethics Board</i> was obtained for this retrospective study (ID#3881).

: Not applicable.

: The authors have no competing interests to declare.

Document is current

Any future updates will be listed below